Skip to main content
. 2020 Sep 8;6(2):433–446. doi: 10.1016/j.bioactmat.2020.08.019

Fig. 2.

Fig. 2

Characterizations of HAD and siRNA@CS-HAD NPs. A: FTIR spectroscopy of Hyaluronic acid dialdehyde (HAD). B: The morphology of the nanoparticles detected by SEM. C: The particle size distribution of siRNA@CS NPs with or without HAD modification. D: Their stability analysis, the particle size, polydispersity index (PDI) and zeta potential were recorded for 6 days.